Press release
Multiplexed Diagnostics Market worth $43.97 billion by 2030 | Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Exclusive Report by 360iResearch
The "Multiplexed Diagnostics Market by Method (High Density Multiplexed Assays, Low Density Multiplexed Assays, Mid-Density Multiplexed Assays), Application (Allergic Diseases, Autoimmune Diseases, Cardiology), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/multiplexed-diagnostics?utm_source=openpr&utm_medium=referral&utm_campaign=sample
The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Multiplexed Diagnostics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
Market Segmentation & Coverage:
This research report categorizes the Global Multiplexed Diagnostics Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Method, market is studied across High Density Multiplexed Assays, Low Density Multiplexed Assays, Mid-Density Multiplexed Assays, and Very High Density Multiplexed Assays. The Low Density Multiplexed Assays commanded largest market share of 32.48% in 2022, followed by High Density Multiplexed Assays.
Based on Application, market is studied across Allergic Diseases, Autoimmune Diseases, Cardiology, Infectious Diseases, and Oncology. The Infectious Diseases commanded largest market share of 23.28% in 2022, followed by Oncology.
Based on End-User, market is studied across Academic Research, Clinical Research, Diagnostic Labs, Hospitals, and Pharma Companies. The Diagnostic Labs commanded largest market share of 38.48% in 2022, followed by Clinical Research.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 41.92% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Global Multiplexed Diagnostics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Multiplexed Diagnostics Market, including Abbott Laboratories, AccuBioTech Co., Ltd., Agilent Technologies, Inc., Akoya Biosciences, AusDiagnostics by R-Biopharm, Baxter International Inc, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health, Chembio, ChromaCode, Inc., Danaher Corporation, Delta Diagnostics BV, F. Hoffmann-La Roche AG, Genabio Diagnostics Inc., Hologic, Inc., Illumina, Inc., Leica Biosystems, Medtronic PLC, Merck KGaA, Novartis AG, PCR Biosystems, QIAGEN N.V., Quansys Biosciences Inc., Seegene, Inc., Siemens Healthineers, Thermo Fisher Scientific, Inc., and West Pharmaceutical Services.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Multiplexed Diagnostics Market, by Method
7. Multiplexed Diagnostics Market, by Application
8. Multiplexed Diagnostics Market, by End-User
9. Americas Multiplexed Diagnostics Market
10. Asia-Pacific Multiplexed Diagnostics Market
11. Europe, Middle East & Africa Multiplexed Diagnostics Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Multiplexed Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Multiplexed Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Multiplexed Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Multiplexed Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Multiplexed Diagnostics Market?
6. What is the market share of the leading vendors in the Global Multiplexed Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Multiplexed Diagnostics Market?
Read More @ https://www.360iresearch.com/library/intelligence/multiplexed-diagnostics?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiplexed Diagnostics Market worth $43.97 billion by 2030 | Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Exclusive Report by 360iResearch here
News-ID: 3219530 • Views: …
More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…

The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…

The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…

The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Multiplexed
Multiplexed Diagnostics Market Forecasted to Reach 2019-2027
Transparency Market Research (TMR) has published a new report titled, 'Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global multiplexed diagnostics market was valued at around US$ 8.7 Bn in 2018 and is projected to grow at a CAGR of 17.9% from 2019 to 2027.
Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1719
Overview
•Diagnostic assays are tests used to assess target analytes, quantitatively or qualitatively,…
Valuable Report on Multiplexed Diagnostics Market, 2021-2026
(Portland, United States): A new market research report by Big Market Research on Multiplexed Diagnostics Market reveals that the market is estimated to grow with a substantial growth rate from 2021-2026. This report is a valuable document for major players and the new entrants to scrutinize the market in detail. The insights offered in the report will help the market players to formulate their business strategies and achieve a vital…
Multiplexed Diagnostics Market to Witness Revolutionary Growth
Transparency Market Research (TMR) has published a new report titled, ‘Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global multiplexed diagnostics market was valued at around US$ 8.7 Bn in 2018 and is projected to grow at a CAGR of 17.9% from 2019 to 2027.
Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1719
Overview
Diagnostic assays are tests used to assess target analytes, quantitatively or qualitatively, in biochemical substances, cells of an organism, or an organic…
RFmondial demonstrates multiplexed DRM at IBC 2019
Hannover, 12.09.2019 – RFmondial demonstrates its advanced multiplexed DRM modulation for the FM band, that allows broadcasters to transmit multiple DRM channels on one physical transmitter.
The newest member of RFmondial’s successful LV-series of DRM modulators and exciters allows the parallel generation and transmission of up to six pure digital DRM channels, or in combined analog and digital „Simulcast” mode, one traditional analog FM channel and up to four DRM channels.
„The…
Multiplexed Diagnostics Market 2017 Specifications and Applications Analysis
Summary:
Latest Research Report “Global Multiplexed Diagnostics Market” Added by Orbis Research which covers Market Overview, Product Specification, Profit, Production, Capacity Utilization, Supply, Manufacturing Process & Cost Structure for Different Regions.
2017 Market Research Report on Multiplexed Diagnostics Industry was a professional and depth research report on Multiplexed Diagnostics industry that you would know the world's major regional market conditions of Multiplexed Diagnostics industry, the main region including North American, Europe and…
Multiplexed Diagnostics Market 2024 - Analysis and Trends
Global Multiplexed Diagnostics Market: Snapshot
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify…